Infectious Diseases News and Research

RSS

New York Blood Center and Columbia University partner to advance the use of mRNA technology in HIV vaccine study

New York Blood Center’s Project ACHIEVE and Columbia University’s Columbia Research Unit are working in partnership for the New York City effort to advance the use of messenger ribonucleic acid (mRNA) technology in an HIV preventive vaccine study – HVTN 302.

23 Mar 2022

Scientists identify a promising strategy for stopping Ebola virus polymerase

To treat Ebola virus infections, researchers are taking a close look at a key piece of the virus: polymerase.

23 Mar 2022

Breakthrough hospitalizations for COVID-19, less likely to happen in vaccinated or previously infected people

Fewer than 1 in 1,000 people who have been vaccinated or previously infected with COVID-19 were hospitalized with a new breakthrough infection, Mayo Clinic research finds.

22 Mar 2022

Powerful tool to monitor membrane proteins trafficking for drug discovery

Inside your body on the surface of cell membranes, a metaphorical communication and traffic network is underway as hormones - or chemical messengers - bind to cell membrane receptors to fine tune how the cell behaves.

22 Mar 2022

WVU researcher unravels role of STAT5 protein in the development of multiple sclerosis

A human immune system is a lot like the board game Mouse Trap: it's a Rube Goldberg system of interacting parts. Only instead of a falling ball causing a tiny diver to leap into a tub - which, in turn, springs a trap on some plastic mice - proteins trigger other proteins to activate immune cells and direct them toward germs.

22 Mar 2022

Research reveals significant decrease in gastrointestinal infections during first 6 months of the pandemic

The number of reported gastrointestinal infection outbreaks more than halved during the first 6 months of the COVID-19 pandemic in the UK, compared with the previous 5-year average, while lab confirmed cases fell by a third, finds research published in the open access journal BMJ Open.

22 Mar 2022

The effect of the COVID-19 vaccination campaign on 250 cities in Israel

A recent study assessed the impact of COVID-19 vaccines on unvaccinated populations and analyzed the various vaccination policies in Israel.

22 Mar 2022

Study: Ketogenic diet helps kill pancreatic cancer cells when combined with a triple-drug therapy

The findings of a new study suggest that a ketogenic diet - which is low in carbohydrates and protein, but high in fat - helps to kill pancreatic cancer cells when combined with a triple-drug therapy developed by the Translational Genomics Research Institute (TGen), an affiliate of City of Hope.

22 Mar 2022

New research proves benefit of vaccination after recovery from COVID-19

When our immune system comes into contact with the SARS-CoV-2 coronavirus, it fights back and produces antibodies.

22 Mar 2022

Using CRISPR/Cas to develop biosafety materials

Researchers discuss the use of the highly efficient CRISPR/Cas technologies to identify viral genome sequences for biosafety purposes.

21 Mar 2022

Mount Sinai launches phase 1 study to evaluate the safety, immunogenicity of egg-based COVID-19 vaccine

A team of clinical investigators at the Icahn School of Medicine at Mount Sinai has announced the launch of a Phase 1, open-label, placebo-controlled study to evaluate the safety and immunogenicity of an egg-based COVID-19 vaccine in healthy, vaccinated adults who have never been infected with COVID-19.

21 Mar 2022

Study explores decline in tuberculosis cases during COVID-19 pandemic in the United States

Researchers analyzed a pharmacy dataset to evaluate the 20% decrease in tuberculosis cases reported in 2020 by the US National Tuberculosis Surveillance System.

21 Mar 2022

Pfizer CEO pushes yearly shots for covid. Not so fast, experts say.

When Pfizer CEO Albert Bourla said March 13 that all Americans would need a second booster shot, it struck many covid experts as a self-serving remark without scientific merit. It also set off spasms of doubt over the country's objectives in its fight against the coronavirus.

21 Mar 2022

Texas Biomed and UAB partnership uncovers a new, potent antibody cocktail against all coronaviruses

As SARS-CoV-2 has continued to evolve and outsmart existing treatments, scientists have not let up looking for ever-more effective tools to keep people safe and successfully recover from COVID-19, and to prepare for future outbreaks.

18 Mar 2022

Covalent protein nanobodies for neutralizing SARS-CoV-2 and its variants

Researchers developed covalent nanobodies to neutralize severe acute respiratory syndrome coronavirus-2 and its variants.

18 Mar 2022

Presence of zoonotic pathogens in wildlife market for human consumption in Laos

Researchers from different countries examined various animal species from wildlife trade sites to detect the presence of zoonotic pathogens in Laos, South East Asia.

18 Mar 2022

Innate and adaptive immune responses to BNT162b2 vaccination in mice

Researchers analyzed the innate and adaptive responses to the mRNA-based BNT162b2 COVID-19 vaccine in mice.

18 Mar 2022

Duration of Omicron variant shedding isolated from upper respiratory samples collected from the reported case-patients in Japan

Researchers conducted a retrospective analysis to evaluate the duration of the SARS-CoV-2 Omicron variant virus shedding

18 Mar 2022

SARS-CoV-2 burden and transmission in one rural and one urban community in South Africa

Researchers conducted a prospective household cohort study of COVID-19, influenza, and respiratory syncytial virus community burden, viral interaction, and transmission dynamics, called PHIRST-C study in South Africa.

18 Mar 2022

Breakthrough infection could provide broad protection against current SARS-CoV-2 variants of concern

A delta breakthrough infection generates a potent and broad neutralizing antibody response in double vaccinated individuals, according to new research.

17 Mar 2022

Infectious Diseases News and Research

New York Blood Center and Columbia University partner to advance the use of mRNA technology in HIV vaccine study

Scientists identify a promising strategy for stopping Ebola virus polymerase

Breakthrough hospitalizations for COVID-19, less likely to happen in vaccinated or previously infected people

Powerful tool to monitor membrane proteins trafficking for drug discovery

WVU researcher unravels role of STAT5 protein in the development of multiple sclerosis

Research reveals significant decrease in gastrointestinal infections during first 6 months of the pandemic

The effect of the COVID-19 vaccination campaign on 250 cities in Israel

Study: Ketogenic diet helps kill pancreatic cancer cells when combined with a triple-drug therapy

New research proves benefit of vaccination after recovery from COVID-19

Using CRISPR/Cas to develop biosafety materials

Mount Sinai launches phase 1 study to evaluate the safety, immunogenicity of egg-based COVID-19 vaccine

Study explores decline in tuberculosis cases during COVID-19 pandemic in the United States

Pfizer CEO pushes yearly shots for covid. Not so fast, experts say.

Texas Biomed and UAB partnership uncovers a new, potent antibody cocktail against all coronaviruses

Covalent protein nanobodies for neutralizing SARS-CoV-2 and its variants

Presence of zoonotic pathogens in wildlife market for human consumption in Laos

Innate and adaptive immune responses to BNT162b2 vaccination in mice

Duration of Omicron variant shedding isolated from upper respiratory samples collected from the reported case-patients in Japan

SARS-CoV-2 burden and transmission in one rural and one urban community in South Africa

Breakthrough infection could provide broad protection against current SARS-CoV-2 variants of concern

Industry Focus: Infectious Diseases eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News